A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: To date, the five-year survival rate of early stages of non-small cell lung cancer (NSCLC) is still disappointing and reliable prognostic factors are mandatory. Here, we performed in-depth high-throughput analyses of plasma circulating markers, including exosomal microRNAs and peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconi, Silvia, Croce, Michela, Chiorino, Giovanna, Rossi, Giovanni, Guana, Francesca, Profumo, Aldo, Ostano, Paola, Alama, Angela, Longo, Luca, De Luca, Giuseppa, Dono, Mariella, Dal Bello, Maria Giovanna, Ponassi, Marco, Rosano, Camillo, Romano, Paolo, Cavalieri, Zita, Grassi, Massimiliano, Tagliamento, Marco, Zullo, Lodovica, Venturi, Consuelo, Dellepiane, Chiara, Mastracci, Luca, Bennicelli, Elisa, Pronzato, Paolo, Genova, Carlo, Coco, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317031/
https://www.ncbi.nlm.nih.gov/pubmed/35884472
http://dx.doi.org/10.3390/cancers14143412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317031/
https://www.ncbi.nlm.nih.gov/pubmed/35884472
http://dx.doi.org/10.3390/cancers14143412

Ejemplares similares